Back
September 28, 2026
•
1 minute read

Longtime Collaborator and Alzheimer's Researcher Jacob Vogel, PhD Joins Centile Bio as Scientific Advisor

News
No items found.

Share Article

Table of Contents

Centile Bio welcomes Jacob Vogel, PhD, to its Advisory Board as a Scientific Advisor. Jake is a computational neuroscientist specializing in brain aging across the lifespan, machine learning, and neurodegenerative disease.

Jake and Centile Bio co-founder Jakob Seidlitz, PhD, have co-authored multiple high-impact scientific publications, including “Brain charts for the human lifespan.” Published in Nature in 2022, this peer-reviewed study established population-referenced brain charts across the human lifespan and formed the scientific foundation of Centile Bio’s approach to quantitative neuroimaging for precision medicine.

Jake is an Assistant Professor in Lund University’s Department of Clinical Sciences, Malmö, where he leads the Dementia Multi-Omics and Neuroimaging (DeMON) lab, and a Data-Driven Life Science (DDLS) Fellow affiliated with SciLifeLab. His research integrates brain imaging, tau-PET, and molecular data to study neurodegenerative disease.

Jake’s work in AI and Alzheimer’s research gives him a valuable perspective on which tools matter, how to apply them to answer critical clinical questions, and how to integrate imaging with other data to deepen the analysis. His guidance on the technical aspects of the platform and his knowledge of neurodegenerative disease will help us build a stronger foundation for the questions clinicians and research teams can ask of imaging data they already have."

— Jakob Seidlitz, PhD, Co-founder and CEO, Centile Bio

In a 2021 Nature Medicine study, he identified four distinct trajectories of tau accumulation in Alzheimer’s disease, revealing differences in how the disease progresses across individuals.

Neurodegenerative diseases do not follow a single biological course, and imaging captures only part of that complexity. Studying imaging alongside molecular markers and clinical outcomes, from population patterns to individual trajectories, is essential to understanding those differences. I look forward to helping Centile make this work more accessible to teams working toward better diagnosis, care, and treatment."

— Jacob Vogel, PhD, Scientific Advisor, Centile Bio

He began his research career at the University of California, Berkeley, earned his Ph.D. from McGill University, and completed postdoctoral training at the University of Pennsylvania.

In 2023, Jake received H.M. Queen Silvia’s Prize for a Young Alzheimer’s Researcher, and in 2026, the Alzheimer’s Research Foundation European Young Researcher Prize, in recognition of his contributions to the field.

Meet the team